- Home
- Publications
- Publication Search
- Publication Details
Title
Current developments in gene therapy for epidermolysis bullosa
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume -, Issue -, Pages 1-14
Publisher
Informa UK Limited
Online
2022-03-03
DOI
10.1080/14712598.2022.2049229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice
- (2021) Sikai Ling et al. Nature Biomedical Engineering
- Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq
- (2021) Giandomenico Turchiano et al. Cell Stem Cell
- Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
- (2021) Jose Bonafont et al. MOLECULAR THERAPY
- Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
- (2021) Michael Ablinger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice
- (2021) Pengpeng Liu et al. Nature Communications
- Gene Replacement Therapies for Genodermatoses: A Status Quo
- (2021) Ulrich Koller et al. Frontiers in Genetics
- Highly branched poly(β-amino ester)s for gene delivery in hereditary skin diseases
- (2021) Ming Zeng et al. ADVANCED DRUG DELIVERY REVIEWS
- Enhancing prime editing by Csy4-mediated processing of pegRNA
- (2021) Yao Liu et al. CELL RESEARCH
- Research Techniques Made Simple: Delivery of the CRISPR/Cas9 Components into Epidermal Cells
- (2021) Huishan Shi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Optimized nickase- and nuclease-based prime editing in human and mouse cells
- (2021) Fatwa Adikusuma et al. NUCLEIC ACIDS RESEARCH
- A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa
- (2021) Thomas Kocher et al. Molecular Therapy-Nucleic Acids
- In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
- (2021) Matthew Behr et al. Acta Pharmaceutica Sinica B
- Enhanced prime editing systems by manipulating cellular determinants of editing outcomes
- (2021) Peter J. Chen et al. CELL
- Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
- (2021) Franciscus Vermeer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Future Perspectives of Oral Delivery of Next Generation Therapies for Treatment of Skin Diseases
- (2021) Pia Pernille Søgaard et al. Pharmaceutics
- Consensus re‐classification of inherited epidermolysis bullosa and other disorders with skin fragility
- (2020) C. Has et al. BRITISH JOURNAL OF DERMATOLOGY
- Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa
- (2020) Thomas Kocher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
- (2020) Jordan L. Doman et al. NATURE BIOTECHNOLOGY
- Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
- (2020) Yu Zhang et al. Science Advances
- Context-Dependent Strategies for Enhanced Genome Editing of Genodermatoses
- (2020) Oliver Patrick March et al. Cells
- Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system
- (2020) Munenari Itoh et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Directed evolution of adenine base editors with increased activity and therapeutic application
- (2020) Nicole M. Gaudelli et al. NATURE BIOTECHNOLOGY
- Improving Precise CRISPR Genome Editing by Small Molecules: Is there a Magic Potion?
- (2020) Nadja Bischoff et al. Cells
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
- (2020) Tuo Wei et al. ACS Nano
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
- (2020) Fathema Uddin et al. Frontiers in Oncology
- Non-viral strategies for delivering genome editing enzymes
- (2020) Jie Li et al. ADVANCED DRUG DELIVERY REVIEWS
- QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study
- (2020) Olivier Bornert et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Predicting the efficiency of prime editing guide RNAs in human cells
- (2020) Hui Kwon Kim et al. NATURE BIOTECHNOLOGY
- Prime editing for functional repair in patient-derived disease models
- (2020) Imre F. Schene et al. Nature Communications
- Epidermolysis bullosa
- (2020) Ajoy Bardhan et al. Nature Reviews Disease Primers
- Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?
- (2020) Katherine A. High Nature Communications
- CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
- (2019) Grégoire Cullot et al. Nature Communications
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing
- (2019) Jose Bonafont et al. MOLECULAR THERAPY
- Efficient gene reframing therapy for recessive dystrophic epidermolysis bullosa using CRISPR/Cas9
- (2019) Shota Takashima et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Gene editing-mediated disruption of epidermolytic ichthyosis-associated KRT10 alleles restores filament stability in keratinocytes
- (2019) Oliver Patrick March et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Microhomologies are prevalent at Cas9-induced larger deletions
- (2019) Dominic D G Owens et al. NUCLEIC ACIDS RESEARCH
- Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa
- (2019) Laura De Rosa et al. Cell Reports
- Collagen VII Expression is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes
- (2019) Dorothy M. Supp et al. CELL TRANSPLANTATION
- Gene Therapy for Epidermolysis Bullosa
- (2019) M. Peter Marinkovich et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application
- (2019) Sikandar Hayat Khan Molecular Therapy-Nucleic Acids
- Efficient and Robust Highly Branched Poly(β-amino ester)/Minicircle COL7A1 Polymeric Nanoparticles for Gene Delivery to Recessive Dystrophic Epidermolysis Bullosa Keratinocytes
- (2019) Ming Zeng et al. ACS Applied Materials & Interfaces
- Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs
- (2019) Mark J. Osborn et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CRISPR DNA base editors with reduced RNA off-target and self-editing activities
- (2019) Julian Grünewald et al. NATURE BIOTECHNOLOGY
- Improved double-nicking strategies for COL7A1 editing by homologous recombination
- (2019) Thomas Kocher et al. Molecular Therapy-Nucleic Acids
- Rational designs of in vivo CRISPR-Cas delivery systems
- (2019) Cong-Fei Xu et al. ADVANCED DRUG DELIVERY REVIEWS
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells
- (2019) Joanna Jacków et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy
- (2018) Peng Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- RNA Trans-Splicing Modulation via Antisense Molecule Interference
- (2018) Bernadette Liemberger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- How cells ensure correct repair of DNA double-strand breaks
- (2018) Joonyoung Her et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks
- (2018) Eva K. Brinkman et al. MOLECULAR CELL
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse
- (2018) Xiao-Rui Luan et al. Molecular Therapy-Nucleic Acids
- Ex vivo COL7A1 correction for Recessive Dystrophic Epidermolysis Bullosa using CRISPR/Cas9 and Homology Directed Repair
- (2018) Araksya Izmiryan et al. Molecular Therapy-Nucleic Acids
- An ex-vivo RNA trans -splicing strategy to correct human generalized severe epidermolysis bullosa simplex
- (2018) P. Peking et al. BRITISH JOURNAL OF DERMATOLOGY
- CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient
- (2018) Daniela Benati et al. MOLECULAR THERAPY
- ‘Cold shock’ increases the frequency of homology directed repair gene editing in induced pluripotent stem cells
- (2018) Q. Guo et al. Scientific Reports
- Target-Specific Precision of CRISPR-Mediated Genome Editing
- (2018) Anob M. Chakrabarti et al. MOLECULAR CELL
- Base editing: precision chemistry on the genome and transcriptome of living cells
- (2018) Holly A. Rees et al. NATURE REVIEWS GENETICS
- Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells
- (2017) Johann W. Bauer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases
- (2017) Thomas Kocher et al. MOLECULAR THERAPY
- COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
- (2017) Stefan Hainzl et al. MOLECULAR THERAPY
- Regeneration of the entire human epidermis using transgenic stem cells
- (2017) Tobias Hirsch et al. NATURE
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Delivery technologies for genome editing
- (2017) Hao Yin et al. NATURE REVIEWS DRUG DISCOVERY
- An RNA-targeted therapy for dystrophic epidermolysis bullosa
- (2017) Patricia Peking et al. NUCLEIC ACIDS RESEARCH
- Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model
- (2017) Wenbo Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
- (2017) Leonela Amoasii et al. Science Translational Medicine
- Optimization of trans-Splicing for Huntington's Disease RNA Therapy
- (2017) Hansjörg Rindt et al. Frontiers in Neuroscience
- Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks
- (2017) Fei Song et al. Molecular Therapy-Nucleic Acids
- Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients
- (2017) Magomet Aushev et al. Molecular Therapy-Methods & Clinical Development
- Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
- (2017) Kunwoo Lee et al. Nature Biomedical Engineering
- A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa
- (2016) Lara Cutlar et al. EXPERIMENTAL DERMATOLOGY
- Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations
- (2016) B Tockner et al. GENE THERAPY
- Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa
- (2016) Zurab Siprashvili et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model
- (2016) Sandrina Turczynski et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector
- (2016) Joanna Jacków et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Meganuclease-Mediated COL7A1 Gene Correction for Recessive Dystrophic Epidermolysis Bullosa
- (2016) Araksya Izmiryan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB
- (2016) Christos Georgiadis et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa
- (2016) Satoru Shinkuma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lentiviral vectors, two decades later
- (2016) L. Naldini et al. SCIENCE
- mRNAtrans -splicing in gene therapy for genetic diseases
- (2016) Adeline Berger et al. Wiley Interdisciplinary Reviews-RNA
- A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair
- (2016) Patricia Peking et al. Molecular Therapy-Nucleic Acids
- Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes
- (2016) Cristina Chamorro et al. Molecular Therapy-Nucleic Acids
- Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases
- (2016) Diane Yang et al. Scientific Reports
- Regulation of keratin network organization
- (2015) Fanny Loschke et al. CURRENT OPINION IN CELL BIOLOGY
- Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection
- (2015) Xiquan Liang et al. JOURNAL OF BIOTECHNOLOGY
- Error-Prone Repair of DNA Double-Strand Breaks
- (2015) Kasey Rodgers et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Homology and enzymatic requirements of microhomology-dependent alternative end joining
- (2015) S Sharma et al. Cell Death & Disease
- Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
- (2014) Jo-David Fine et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Gold Nanoparticles for Nucleic Acid Delivery
- (2014) Ya Ding et al. MOLECULAR THERAPY
- Tropism-modified AAV Vectors Overcome Barriers to Successful Cutaneous Therapy
- (2014) Jessica Sallach et al. MOLECULAR THERAPY
- Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
- (2014) Steven Lin et al. eLife
- Homing endonucleases from mobile group I introns: discovery to genome engineering
- (2014) Barry L Stoddard Mobile DNA
- Considerations for a Successful RNA Trans-splicing Repair of Genetic Disorders
- (2014) Ulrich Koller et al. Molecular Therapy-Nucleic Acids
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- Corrigendum: Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients
- (2013) MOLECULAR THERAPY
- TALEN-based Gene Correction for Epidermolysis Bullosa
- (2013) Mark J Osborn et al. MOLECULAR THERAPY
- A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype
- (2013) Brian L Ellis et al. Virology Journal
- Long-Term Stability and Safety of Transgenic Cultured Epidermal Stem Cells in Gene Therapy of Junctional Epidermolysis Bullosa
- (2013) Laura De Rosa et al. Stem Cell Reports
- Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
- (2012) Frank Rigo et al. Nature Chemical Biology
- Targeting G with TAL Effectors: A Comparison of Activities of TALENs Constructed with NN and NK Repeat Variable Di-Residues
- (2012) Michelle L. Christian et al. PLoS One
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- An unbiased genome-wide analysis of zinc-finger nuclease specificity
- (2011) Richard Gabriel et al. NATURE BIOTECHNOLOGY
- A novel screening system improves genetic correction by internal exon replacement
- (2011) U. Koller et al. NUCLEIC ACIDS RESEARCH
- SIN Retroviral Vectors Expressing COL7A1 Under Human Promoters for Ex Vivo Gene Therapy of Recessive Dystrophic Epidermolysis Bullosa
- (2010) Matthias Titeux et al. MOLECULAR THERAPY
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
- (2010) Josiane E. Garneau et al. NATURE
- Exon Exchange Approach to Repair Duchenne Dystrophin Transcripts
- (2010) Stéphanie Lorain et al. PLoS One
- The human keratins: biology and pathology
- (2008) Roland Moll et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases
- (2008) Y. Santiago et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endings
- (2008) Mitch McVey et al. TRENDS IN GENETICS
- 5′ Trans-Splicing Repair of the PLEC1 Gene
- (2007) Verena Wally et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation